Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK ( TheStreet) -- We need the world's leaders to wake up and realize the European problem is now a global problem, Jim Cramer told his "Mad Money" viewers Friday after a miserable day on Wall Street. Cramer said the markets have given up their gains for the year so the time to act is now. Make no mistake, the indecision in Europe will cause a global recession, and no one is immune to this crisis. Cramer said he can't blame investors for wanting to sell everything and sit on the sidelines while the world's troubles play out, but socking money away in U.S. Treasuries is not the smartest move. Cramer said there are still bull markets out there, albeit small ones, and there are still companies immune to Europe's woes. The key is to find them. That's why on Monday Cramer will be watching for news from the American Society of Clinical Oncology conference. He said presentations from Johnson & Johnson ( JNJ) and Celgene ( CELG) could move the needle for those companies, regardless of the European news of the day. Also on the radar for Monday, Dollar General ( DG), a company that may finally be feeling the pressure from Wal-Mart ( WMT). Cramer said any weakness in Dollar General would make Wal-Mart a buy. Tuesday brings Ulta Salon ( ULTA), a stock that's gained 60% over the past 12 months. Cramer said Ulta remains a favorite. On Wednesday, Cramer said he will watch oil inventories as any stabilization in oil would actually be a good thing for the markets because fears of continued economic slowing would evaporate. On Thursday, Cramer said another retail favorite, Lululemon Athletica ( LULU), will report earnings. If Lulu is strong, all of the growth stocks including Starbucks ( SBUX), Chipotle Mexican Grill ( CMG) and even Apple ( AAPL), a stock which Cramer owns for his charitable trust,
Fun With SpeculationSpeculation keeps investing fun, Cramer told viewers, and he highlighted one such stock on what he affectionately called "Speculation Friday." Today's company: Lithia Motors ( LAD), an auto dealership chain with 84 locations in 11 western states.
Cramer said for investors who are bullish on the American consumer, Lithia is the perfect speculative stock. Lithia is domestic and it's in a fragmented market with tons of room to grow. In its most recent quarter, Lithia increased its same-store sales by a stellar 22%, with new car sales growing by 25%. Compare that to the next closest competitor, Sonic Automotive ( SAH), which only grew by 12.1%. In addition to sales, Lithia has great margins and is taking market share from its rivals. Cramer said Lithia clearly knows what works and offers not only sales, but service, financing and insurance, three services with high margins and steady income streams. Service alone accounts for 32% of Lithia's profits. Despite beating Wall Street expectations by 18 cents a share, Lithia remains the cheapest of all the auto dealership stocks, said Cramer. But as great as Lithia may be, Cramer said he still cannot recommend the stock given the weak unemployment data received today. Consumers stopped buying cars before, he said, and they may stop again. For investors who are bullish on American growth however, Lithia "may be the stock for you."
Circling the WagonsIn a terrible market, it pays to circle the wagons around recession-resistant company you can count on, Cramer said. Investors can't just invest for today, they must invest in the bargains that are being created, the stocks with high yields that will snap back quickly. That's why Cramer recommended Johnson & Johnson, a once-hated company that now sports a new CEO and a 4% dividend yield. Cramer said that J&J is now a potential breakup story as the company is actually three businesses in one. According to a recent research report, J&J could split itself into a pharmaceutical company, a consumer products company and a medical devices company, thus unlocking $76 a share worth of value, a 23% premium from today prices. Breakups in health care work, Cramer reminded viewers, as evidenced by Abbott Labs ( ABT), another Action Alerts PLUS holding, as well as Pfizer ( PFE) and Covidian ( COV). But even without a breakup, Cramer said he's a believer in new CEO Alex Gorsky. He said a fresh set of eyes can do wonders at a company and Gorsky, a long-time J&J employee, will know his way around. Unlike other drug makers, Johnson & Johnson is largely past its wave of patent expirations, said Cramer, and the company has a slew of new drugs set to power future growth.
So as the market puts great stocks on sale, Cramer advised viewers to load up the truck on safe dividend stocks like Johnson & Johnson, ones that could surprise with plans to unlock even more value from their company.